UNIGE document Scientific Article
previous document  unige:78633  next document
add to browser collection

Maladies hépatiques chroniques et diabète

Scheen, André
Published in Revue médicale suisse. 2014, vol. 10, no. 433, p. 1254-1260
Abstract The presence of chronic liver diseases may drastically limit the use of anti-diabetic drugs. Chronic liver diseases increase insulin resistance, and in some risk groups promote the development of diabetes. Therefore, antidiabetic treatment should be adapted to the severity of liver disease. However, diabetes, notably when associated with obesity and dyslipidemia, participates in the development of nonalcoholic fatty liver disease and to steato-hepatitis that may progress to cirrhosis and hepatocellular carcinoma. Other relations between diabetes and chronic liver disease will be discussed in this article. Finally, the indications and limits of each anti-diabetic therapy group will be discussed according to the degree of liver damage.
Keywords Blood Glucose/metabolismChronic DiseaseDiabetes Mellitus, Type 2/drug therapy/etiologyHumansHypoglycemic Agents/administration & dosage/contraindications/therapeutic useLiver Diseases/complications
PMID: 25004772
Full text
Article (Published version) (1.1 MB) - document accessible for UNIGE members only Limited access to UNIGE
Research group Diabète et régulation des gènes (36)
(ISO format)
JAAFAR, Jaafar et al. Maladies hépatiques chroniques et diabète. In: Revue médicale suisse, 2014, vol. 10, n° 433, p. 1254-1260. https://archive-ouverte.unige.ch/unige:78633

227 hits

0 download


Deposited on : 2015-12-14

Export document
Format :
Citation style :